Diagnostic utility of calretinin immunohistochemistry in cytologic cell block preparations

Calretinin (CR) is a valuable marker in the immunohistochemical distinction between malignant mesothelioma (MM) and adenocarcinoma (ACA) in tissue sections. However, there is limited and conflicting data regarding the utility of CR in this differential diagnosis on cytologic material, especially cell block preparations. Also, the possible role of CR in the distinction of papillary serous borderline tumor (SBT) cells from reactive mesothelial cells in peritoneal washings has not been examined.

[1]  Y. Inayama,et al.  Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma , 2000, Cancer.

[2]  A. Nicholson,et al.  Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the Pleura , 2000, Modern Pathology.

[3]  N. Ordóñez.  Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma. Review and update. , 1999, American journal of clinical pathology.

[4]  C. Genton,et al.  Selective distribution of calretinin in adenocarcinomas of the human colon and adjacent tissues. , 1999, The American journal of surgical pathology.

[5]  M. Zakowski,et al.  E‐cadherin, N‐cadherin, and calretinin in pleural effusions: The good, the bad, the worthless , 1999, Diagnostic cytopathology.

[6]  N. Ordóñez.  Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[7]  N. Ordóñez.  Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas. , 1998, The American journal of surgical pathology.

[8]  Leers,et al.  E‐cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma , 1998, Histopathology.

[9]  B. Hemmerlein,et al.  The value of anti-calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology. , 1998, Pathology, research and practice.

[10]  C. Genton,et al.  Selective immunocytochemical localisation of calretinin in the human ovary , 1997, Histochemistry and Cell Biology.

[11]  J. Riera,et al.  The immunohistochemical diagnostic panel for epithelial mesothelioma: a reevaluation after heat-induced epitope retrieval. , 1997, The American journal of surgical pathology.

[12]  G. Viale,et al.  Calretinin. A selective marker of normal and neoplastic mesothelial cells in serous effusions. , 1997, Acta cytologica.

[13]  L. Pisharodi,et al.  Cytopathology of serous neoplasia of the ovary and the peritoneum: Differential diagnosis from mesothelial proliferations , 1996, Diagnostic cytopathology.

[14]  G. Viale,et al.  Calretinin: a novel immunocytochemical marker for mesothelioma. , 1996, The American journal of surgical pathology.

[15]  A. Behrens,et al.  Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. , 1996, Journal of the National Cancer Institute.

[16]  R. Hoda.  The Art and Science of Cytopathology , 1996 .

[17]  A. Thor,et al.  The art and science of cytopathology: Richard M. DeMay, MD. Chicago IL, ASCP Press, 1996, 2 vol set, 1,289 pages, $285 , 1996 .

[18]  P. Vogt,et al.  The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type. , 1996, Pathology, research and practice.

[19]  A. Vecchione,et al.  CA 125 in ovarian cysts, serous effusions and peritoneal washings: immunocytochemical expression. , 1995, Anticancer research.

[20]  P. Clement,et al.  Florid Mesothelial Hyperplasia Associated with Ovarian Tumors: A Potential Source of Error in Tumor Diagnosis and Staging , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[21]  N. Sneige,et al.  Peritoneal washing cytology in women: Diagnostic pitfalls and clues for correct diagnosis , 1992, Diagnostic cytopathology.

[22]  H. Battifora,et al.  Immunocytochemical profile of benign and carcinomatous effusions. A practical approach to difficult diagnosis. , 1990, American journal of clinical pathology.

[23]  E. Ravinsky.  Cytology of peritoneal washings in gynecologic patients. Diagnostic criteria and pitfalls. , 1986, Acta cytologica.

[24]  H. Battifora,et al.  Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach , 1985, Cancer.

[25]  B. Atkinson,et al.  Peritoneal washing cytology. Uses and diagnostic criteria in gynecologic neoplasms. , 1984, Acta cytologica.

[26]  P. Betta,et al.  Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesothelioma , 1984, Cancer.

[27]  R. Scully,et al.  Peritoneal fluid cytology in patients with ovarian cancer. , 1984, Gynecologic oncology.

[28]  G. Pinkus,et al.  Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. , 1982, The American journal of pathology.